https://www.marketscreener.com/quote/stock/MAXCYTE-INC-26786499/news/MaxCyte-Inc-Signs-Strategic-Platform-License-with-Imugene-to-Advance-Their-Cancer-Immunotherapy-Pr-45794437/?utm_source=telegram&utm_medium=social&utm_campaign=share